Skip to main content

Dr. Nicolae Leca

Nephrology (Kidney) (Nephrology Physician)

University Of Washington Medical Ctr, 1959 Ne Pacific St
Seattle, WA 98195

Who else practices at this address →

King County includes primary care (5% of residents) and dental (4% of residents) and mental health (4% of residents) shortage areas. About shortage areas

Call (206) 598-5068

  • Medicare participating

At a glance

Years since graduation
30
In the NPI registry since
2006
Medicare patients seen, 2024
161

Licensed in Washington since 2005, according to the Washington State Department of Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Nephrology Physician primary
    WA license MD00045108 (first issued 2005; active)
  • Internal Medicine Physician
    WA license MD00045108 (first issued 2005; active)

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Nephrology (Kidney) per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
161
Services billed
710
Patients’ average age
61
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 40-54 minutes348134
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes13150
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes4923
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes2220
Established patient office or other outpatient visit, 30-39 minutes2018

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 7 companies reported 53 payments worth $65,828 in total to this clinician.

By company
Travere Therapeutics, Inc.$22,374
Alexion Pharmaceuticals, Inc.$13,948
Sanofi-aventis U.S. LLC$13,463
Novartis Pharmaceuticals Corporation$9,041
Veloxis Pharmaceuticals, Inc.$4,480
Calliditas Therapeutics US Inc.$2,481
Amgen Inc.$41.59
By type
Consulting Fee$57,642
Travel and Lodging$6,049
Food and Beverage$2,137

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Nov 11, 2025Travere Therapeutics, Inc.
Nov 11, 2025
Consulting Fee$12,950
Dec 4, 2025Alexion Pharmaceuticals, Inc.
Dec 4, 2025
Consulting Fee
ULTOMIRIS · Rare Disease
$11,725
Nov 25, 2025Sanofi-aventis U.S. LLC
Nov 25, 2025
Consulting Fee$8,671
Oct 21, 2025Novartis Pharmaceuticals Corporation
Oct 21, 2025
Consulting Fee
Fabhalta · Immunology
$7,700
Nov 18, 2025Travere Therapeutics, Inc.
Nov 18, 2025
Consulting Fee$6,300
Nov 27, 2025Veloxis Pharmaceuticals, Inc.
Nov 27, 2025
Consulting Fee
ENVARSUS · TRANSPLANTATION
$4,480
Oct 28, 2025Sanofi-aventis U.S. LLC
Oct 28, 2025
Consulting Fee$3,335
Aug 21, 2025Calliditas Therapeutics US Inc.
Aug 21, 2025
Consulting Fee
TARPEYO · NEPHROLOGY
$2,481
Oct 24, 2025Travere Therapeutics, Inc.
Oct 24, 2025
Travel and Lodging
travel to Minneapolis, MN · in-kind
$1,010
Nov 3, 2025Alexion Pharmaceuticals, Inc.
Nov 3, 2025
Travel and Lodging
ULTOMIRIS · Rare Disease · travel to Houston, TX · in-kind
Company’s descriptionConsulting Expenses
$917
All 28 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 4, 2025Alexion Pharmaceuticals, Inc.
Dec 4, 2025
Consulting Fee
ULTOMIRIS · Rare Disease
$11,725
Nov 27, 2025Veloxis Pharmaceuticals, Inc.
Nov 27, 2025
Consulting Fee
ENVARSUS · TRANSPLANTATION
$4,480
Nov 25, 2025Sanofi-aventis U.S. LLC
Nov 25, 2025
Consulting Fee$8,671
Nov 25, 2025Sanofi-aventis U.S. LLC
Nov 25, 2025
Travel and Lodging
travel to Southlake, TX · in-kind
$689
Nov 25, 2025Sanofi-aventis U.S. LLC
Nov 25, 2025
Travel and Lodging
travel to Southlake, TX
$74.00
Nov 21, 2025Sanofi-aventis U.S. LLC
Nov 21, 2025
Travel and Lodging
travel to Southlake, TX · in-kind
$271
Nov 18, 2025Travere Therapeutics, Inc.
Nov 18, 2025
Consulting Fee$6,300
Nov 18, 2025Travere Therapeutics, Inc.
Nov 18, 2025
Travel and Lodging
travel to Denver, CO · in-kind
$125
Nov 18, 2025Travere Therapeutics, Inc.
Nov 18, 2025
Travel and Lodging
travel to Denver, CO · in-kind
$30.80
Nov 11, 2025Travere Therapeutics, Inc.
Nov 11, 2025
Consulting Fee$12,950
Nov 11, 2025Travere Therapeutics, Inc.
Nov 11, 2025
Travel and Lodging
travel to Denver, CO · in-kind
$74.00
Nov 4, 2025Alexion Pharmaceuticals, Inc.
Nov 4, 2025
Travel and Lodging
ULTOMIRIS · Rare Disease · travel to Houston, TX · in-kind
Company’s descriptionConsulting Expenses
$350
Nov 3, 2025Alexion Pharmaceuticals, Inc.
Nov 3, 2025
Travel and Lodging
ULTOMIRIS · Rare Disease · travel to Houston, TX · in-kind
Company’s descriptionConsulting Expenses
$917
Nov 3, 2025Alexion Pharmaceuticals, Inc.
Nov 3, 2025
Travel and Lodging
ULTOMIRIS · Rare Disease · travel to Houston, TX · in-kind
Company’s descriptionConsulting Expenses
$350
Nov 3, 2025Alexion Pharmaceuticals, Inc.
Nov 3, 2025
Travel and Lodging
ULTOMIRIS · Rare Disease · travel to Seattle, WA
Company’s descriptionConsulting Expenses
$87.97
Nov 2, 2025Alexion Pharmaceuticals, Inc.
Nov 2, 2025
Travel and Lodging
ULTOMIRIS · Rare Disease · travel to Houston, TX
Company’s descriptionConsulting Expenses
$53.05
Oct 28, 2025Sanofi-aventis U.S. LLC
Oct 28, 2025
Consulting Fee$3,335
Oct 24, 2025Travere Therapeutics, Inc.
Oct 24, 2025
Travel and Lodging
travel to Minneapolis, MN · in-kind
$1,010
Oct 24, 2025Travere Therapeutics, Inc.
Oct 24, 2025
Travel and Lodging
Filspari · Kidney Disease · travel to Denver, CO · in-kind
$446
Oct 24, 2025Travere Therapeutics, Inc.
Oct 24, 2025
Travel and Lodging
Filspari · Kidney Disease · travel to Denver, CO · in-kind
$287
Oct 21, 2025Novartis Pharmaceuticals Corporation
Oct 21, 2025
Consulting Fee
Fabhalta · Immunology
$7,700
Oct 21, 2025Novartis Pharmaceuticals Corporation
Oct 21, 2025
Travel and Lodging
Fabhalta · Immunology · travel to East Hanover, NJ
$74.00
Oct 11, 2025Travere Therapeutics, Inc.
Oct 11, 2025
Travel and Lodging
travel to Minneapolis, MN · in-kind
$240
Oct 2, 2025Novartis Pharmaceuticals Corporation
Oct 2, 2025
Travel and Lodging
Fabhalta · Immunology · travel to East Hanover, NJ · in-kind
$343
Oct 2, 2025Novartis Pharmaceuticals Corporation
Oct 2, 2025
Travel and Lodging
Fabhalta · Immunology · travel to East Hanover, NJ
$262
Oct 2, 2025Novartis Pharmaceuticals Corporation
Oct 2, 2025
Travel and Lodging
Fabhalta · Immunology · travel to East Hanover, NJ
$27.63
Oct 1, 2025Novartis Pharmaceuticals Corporation
Oct 1, 2025
Travel and Lodging
travel to Morristown, NJ · in-kind
$337
Aug 21, 2025Calliditas Therapeutics US Inc.
Aug 21, 2025
Consulting Fee
TARPEYO · NEPHROLOGY
$2,481

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Washington →

Industry-funded research

Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $17,131 in research payments for these studies, mostly to the institutions running them.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Nephrology (Kidney) clinicians in Seattle

Sources

NPI registry (CMS NPPES, November 2026; record last updated June 24, 2009), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1407931215. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.